StockData
AbbVie Inc. logo

AbbVie Inc.

ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026Score 10/3094% above fair value
$288.84−6.05 (-2.05%)

Close on Nov 2, 2026Market cap $510.41BP/E 81.6Yield 2.30%

AbbVie OPEB Obligation Weighted-Average Discount Rate by Year

OPEB Obligation Weighted-Average Discount Rate (%) (%)

AbbVie OPEB Obligation Weighted-Average Discount Rate: 5.6% in FY2025, down 0.1 pts from a year earlier.

Latest, FY2025
5.6%
Period ended Dec 31, 2025
Change on a year earlier
-0.1 pts
5.7% in FY2024
History
10 years
Since FY2016
Sources
9
Documents cited below

Where the FY2025 figure comes from

Source: Form 10-K (filed 2026-02-20) ↗

Reported in Form 10-K Note 12 Post-Employment Benefits.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedOPEB Obligation Weighted-Average Discount Rate (%) (%)Year on yearSource
FY2025Dec 31, 20255.6%-0.1 ptsForm 10-K (filed 2026-02-20) ↗
FY2024Dec 31, 20245.7%+0.6 ptsForm 10-K (filed 2026-02-20) ↗
FY2023Dec 31, 20235.1%-0.2 ptsForm 10-K (filed 2025-02-14) ↗
FY2022Dec 31, 20225.3%+2.2 ptsForm 10-K (filed 2024-02-20) ↗
FY2021Dec 31, 20213.1%+0.3 ptsForm 10-K (filed 2023-02-17) ↗
FY2020Dec 31, 20202.8%-0.8 ptsForm 10-K (filed 2022-02-18) ↗
FY2019Dec 31, 20193.6%-1.0 ptsForm 10-K (filed 2021-02-19) ↗
FY2018Dec 31, 20184.6%+0.7 ptsForm 10-K (filed 2020-02-21) ↗
FY2017Dec 31, 20173.9%-0.8 ptsForm 10-K (filed 2019-02-27) ↗
FY2016Dec 31, 20164.7%–Form 10-K (filed 2018-02-16) ↗

Cite this data

StockData. (2026). AbbVie OPEB Obligation Weighted-Average Discount Rate (%), annual FY2016–FY2025 [Data set]. Compiled from AbbVie SEC filings and investor materials. https://stockdatahq.com/stocks/abbv/kpis/db-opeb-disc-rate

See every metric in the AbbVie KPI table. Data updated Oct 26, 2026.